25 national lowest price "exposure"

Yesterday, Liaoning provincial centralized purchase network of drugs and medical consumables released the notice on publicizing the declaration of drug price information through the green channel of centralized purchase of anticancer drugs and rare disease drugs, which announced the lowest price of 25 drugs on the national network (see the end of the article for the list of drugs), including 2 original research drugs of Roche, 23 local anticancer drugs and rare disease drugs According to the document, in order to further ensure the supply of anticancer drugs and meet the diversified drug demand of patients, a green channel for the procurement of anticancer drugs and drugs for rare diseases is established in accordance with the notice on further ensuring the supply of anticancer drugs and drugs for rare diseases (No 46, 2019) issued by liaoyaocailingban At the same time, the purchase price filled in by the enterprise is explained, that is, according to the requirements of the notice on further ensuring the supply of anticancer drugs and drugs for rare diseases (No 46, ljjgbz 019), the price information filled in refers to the purchase price (excluding the market price and the online self purchase) generated by the centralized purchase methods such as bidding purchase and direct online purchase in all provinces (cities and autonomous regions) of the country The price of anticancer drugs shall be the price after tax reduction and price reduction) In fact, since 4 + 7, price reduction has become the "consensus" of the industry for the market Foreign enterprises have joined in the team of price reduction, and local enterprises do not miss any chance to seize the market Therefore, in this application for purchasing products, several large varieties of Hutchison Whampoa pharmaceutical, such as furquitinib, pyrrolidine maleate of Hengrui, Cinda's cindilimab and rituximab, have been on the market for no more than one year It is worth mentioning that the lenalidomide of Shuanglu once again broke the low price record The price of 25mg * 21 * bottle was originally 5580 yuan, and now it has reached 3960 yuan The price of 10mg * 28 * bottle was originally 5350 yuan, now it is 3660 yuan, and the price of 5mg * 28 * bottle was originally 3660 yuan, now it is 2860 yuan And Qilu pharmaceutical's lenalidomide (25mg * 21 * bottle) is 20 yuan cheaper Lenalidomide is a new generation of oral immunomodulatory drug developed by new gene It was launched in the United States in 2005 and is mainly used in multiple myeloma (mm), myelodysplastic syndrome (MDS) and mantle cell lymphoma (MCL) As the top 2 product in the global sales volume, the global sales volume of the drug reached US $6.974 billion in 2016, US $8.187 billion in 2017 and US $9.685 billion in 2018 But its domestic sales performance is not outstanding It is understood that the sales volume of lenalidomide in the sample hospitals in 2017 is less than 30 million yuan However, with the continuous expansion of lenalidomide indications, the insiders predict that the market space of multiple myeloma in China is about 7.5 billion yuan This is also an important reason why the four giants holding lenalidomide in China (rifume of Xinji, Lisheng of Shuanglu pharmaceutical, Anxian of Zhengda Tianqing and Revlimid of Qilu pharmaceutical) compete for the market In the scramble for lenalidomide, the three local enterprises are very active in price reduction As early as February 2019, the bidding price of 25 mg of Shuanglu Lisheng dropped from 2W to 5580, with a price reduction of 72% On the same day, Zhengda Tianqing Anxian's 25 mg online price in Shandong was 5380 With the listing of Qilu pharmaceutical Revlimid, the price war became more fierce On June 6, Qilu pharmaceutical announced that lenalidomide capsule would be reduced to 3980 and included in Shanghai medical insurance payment, and on June 11, 25mg of Zhengda Tianqing Anxian pharmaceutical announced that it would be reduced to 3970 Today, in order to maintain (fight for) the market of Liaoning Province, lenadelamine of Shuanglu has lowered its bid price to more than 3000 yuan on the basis of a 72% drop, and the drop has exceeded 80%, which is called "bloody battle" Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.